Jump to content
Crime Forum
FORUMS BLOG/NEWS USER BLOGS USER MEDIA ADVERTS   ADD  MANAGE CHAT CLUBS & USER'S PERSONAL FORUMS LINK EXCHANGE
  • entries
    661
  • comments
    0
  • views
    2,144

About this blog

Drug repurposing enables drug developers to optimize on past efforts and expenditure, thereby, offering a viable life cycle management strategy for marketed products and opportunities to re-evaluate failed / shelved drug development programs

 

Roots Analysis is pleased to announce the publication of its recent study, titled, “Drug Repurposing Service Providers Market, 2020-2030.

 

The report features an extensive study of the current market landscape and future opportunities for players offering services for repurposing / repositioning / reprofiling of drug candidates. It features an in-depth analysis, highlighting the capabilities of various service providers engaged in this domain. In addition to other elements, the study includes:

§  A detailed assessment of the current market landscape of companies offering drug repurposing services. 

§  Elaborate profiles of key players that specialize in offering services for the development of repurposed drugs.

§  An analysis of the partnerships that have been established in this domain, in the recent past.

§  An analysis of the initiatives of big biopharma players engaged in this domain.

§  A detailed analysis of more than 1,700 terminated / withdrawn / suspended clinical studies of the drug candidates.

§  A detailed analysis on the cost saving potential of drug repurposing approaches, as compared to the traditional de novo drug development methods.

§  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

  • Type of Repurposing Approaches

§  Disease-centric approach

§  Target-centric approach

§  Drug-centric approach

  • Therapeutic Area

§  Same Therapeutic Area

§  Different Therapeutic Area

  • Type of Drug Molecule

§  Biologics 

§  Small Molecule

  • Key Geographical Region 

§  North America

§  Europe

§  Asia-Pacific

 

Key companies covered in the report

§  Auxillis Pharma

§  ChemBio Discovery Solutions

§  Excelra

§  GVK Bio

§  Iris Pharma

§  Lantern Pharma

§  PanXome

§  Pharmacelera

§  Physiogenex

§  Smart Pharma

§  Socium

§  SOM Biotech

 

For more information please click on the following link:

https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html

 

Other Recent Offerings

1.     Peptides and Macrocycle Drug Discovery: Services and Platforms Market, 2020 - 2030

2.     China Biopharmaceutical Contract Manufacturing Market, 2020-2030

3.     Antibody Contract Manufacturing Market, 2020 - 2030

 

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

 

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com

 

 

Entries in this blog

The global, handheld X-ray imaging devices market is projected to be worth USD 2.8 billion by 2030<Roots>

Roots Analysis has done a detailed study on “Global Handheld X-Ray Imaging Devices Market by Area of Application (Dental and Others), Device Class (Low-End, Mid-End and High-End), End-Users (Ambulatory Surgical Centers, Diagnostic Imaging Centers, Hospitals, Specialty Clinics and Others), and by Key Geographical Regions (North America, Europe, Asia-Pacific, Middle-East and North Africa, Latin America and Rest of the World): Industry Trends and Global Forecasts, 2020-2030” covering key aspects of

The global, handheld X-ray imaging devices market is projected to be worth over USD 2.8 billion: By RootsAnalysis:

Roots Analysis is pleased to announce the publication of its recent study titled, “Global Handheld X-Ray Imaging Devices Market by Area of Application (Dental and Others), Device Class (Low-End, Mid-End and High-End), End-Users (Ambulatory Surgical Centers, Diagnostic Imaging Centers, Hospitals, Specialty Clinics and Others), and by Key Geographical Regions (North America, Europe, Asia-Pacific, Middle-East and North Africa, Latin America and Rest of the World): Industry Trends and Global Forecas

The global, handheld X-ray imaging devices market is projected to be worth USD 2.8 billion by 2030: By Roots:

Roots Analysis has announced the addition of “Global Handheld X-Ray Imaging Devices Market by Area of Application (Dental and Others), Device Class (Low-End, Mid-End and High-End), End-Users (Ambulatory Surgical Centers, Diagnostic Imaging Centers, Hospitals, Specialty Clinics and Others), and by Key Geographical Regions (North America, Europe, Asia-Pacific, Middle-East and North Africa, Latin America and Rest of the World): Industry Trends and Global Forecasts, 2020-2030” report to its list of

The “Digital Health Market: Focus on Digital Therapeutics (2nd Edition), 2020-2030:RootsAnalysis:

https://www.rootsanalysis.com/reports/view_document/digital-health-market/208.html   Key Inclusions §  An overview of the current market landscape of digital therapeutic solutions, including information on status of development, type of solution (combination offering of software application + device or AI or personal coach, and standalone software application), type of therapy (curative and preventive), purpose of solution (medication replacement and medication augmentation), tar

Over 100 industry players are engaged in evaluating the potential of several prescription: Roots:

Recent advances in information technology and biomedical science have enabled the development of a number of versatile digital solutions that are capable of either mimicking or augmenting, the fundamental qualities of pharmacological interventions.   To order this 500+ page report, which features 160+ figures and 200+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/digital-health-market/208.html   The USD 8.86 billion (by 2030) financial opport

The global digital therapeutics market is projected to be worth over USD 8.86 billion by 2030{RootsAnalysis}

Roots Analysis has done a detailed study on Digital Health Market: Focus on Digital Therapeutics (2nd Edition), 2020-2030 (Based on Type of Solution (Software Solution, Gaming Solution and Combination Solution), Type of Therapy (Curative and Preventive), and Purpose of Solution (Medication Replacement and Medication Augmentation” covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 500+ page report, which features 160+

The global digital therapeutics market is projected to be worth over USD 8.8 billion by 2030{Roots}

Roots Analysis is pleased to announce the publication of its recent study titled, “Digital Health Market: Focus on Digital Therapeutics (2nd Edition), 2020-2030 (Based on Type of Solution (Software Solution, Gaming Solution and Combination Solution), Type of Therapy (Curative and Preventive), and Purpose of Solution (Medication Replacement and Medication Augmentation   The report features an extensive study of the current market landscape, offering an informed opinion on the likely ado

The global digital therapeutics market is projected to be worth over USD 8.86 billion by 2030(RootsAnalysis)

Roots Analysis has announced the addition of “Digital Health Market: Focus on Digital Therapeutics (2nd Edition), 2020-2030 (Based on Type of Solution (Software Solution, Gaming Solution and Combination Solution), Type of Therapy (Curative and Preventive), and Purpose of Solution (Medication Replacement and Medication Augmentation” report to its list of offerings.   According to experts, digital therapeutic solutions are primarily based on behavior modification and are designed to addr

The “CAR-T Cell Therapy Market, 2021-2030 (Roots)

Key Inclusions §  A detailed assessment of the current market landscape of CAR-T cell therapies based on the type of developer (industry / non-industry), phase of development (preclinical, phase I, phase I/II, phase II, phase III and approved), therapeutic area (hematological cancer, solid tumor and others), target therapeutic indication (acute lymphoblastic leukemia, non-Hodgkin lymphoma, multiple myeloma, acute myeloid leukemia, brain cancer, chronic lymphocytic leukemia, pancreatic cance

With four approved products and many candidate therapies under evaluation<RootsAnalysis>

Given their ability to selectively direct a cell mediated immune response against cancer cells and, thereby, offer prolonged periods of disease remission, several CAR-T cell therapies provide a promising therapeutic strategy for advanced stage cancers and are expected to achieve blockbuster status. With four approved products and many candidate therapies under evaluation for the treatment of multiple disease indications, the CAR-T cell therapy market is characterized by a healthy and growing pip

The CAR-T Cell therapiesy market is projected to be worth USD 14 billion<Roots>

Roots Analysis has done a detailed study on CAR-T Cell Therapies Market (3rd Edition) by Target Indications (NHL, Multiple Myeloma, Chronic Lymphocytic Leukemia, Acute Lymphoblastic Leukemia, Follicular Lymphoma, Mantle Cell Lymphoma, Hepatocellular Carcinoma and Others), Target Antigens (CD19, BCMA, CD19 / CD22, GPC3 and EGFR), Key Players and Key Geographies (North America, Europe, Asia Pacific, Latin America, Middle East and North Africa, and Rest of the World) – Industry Trends and Global Fo

The CAR-T cell therapy market is estimated to be worth USD 14 billion in 2030: By RootsAnalysis:

Given their ability to selectively direct a cell mediated immune response against cancer cells and, thereby, offer prolonged periods of disease remission, several CAR-T cell therapies are expected to achieve blockbuster status   Roots Analysis is pleased to announce the publication of its recent study, titled, “CAR-T Cell Therapies Market (3rd Edition) by Target Indications (NHL, Multiple Myeloma, Chronic Lymphocytic Leukemia, Acute Lymphoblastic Leukemia, Follicular Lymphoma, Mantle C

The CAR-T therapies market is characterized by a healthy pipeline of promising therapies: By Roots:

Given the success of approved CAR-T cell therapies, such as KYMRIAH®, YESCARTA®, TECARTUS® and BREYANZI®, this upcoming class of biologics are anticipated to carve out a significant share of the multi-billion dollar cancer immunotherapy market   Roots Analysis has announced the addition of “CAR-T Cell Therapies Market (3rd Edition) by Target Indications (NHL, Multiple Myeloma, Chronic Lymphocytic Leukemia, Acute Lymphoblastic Leukemia, Follicular Lymphoma, Mantle Cell Lymphoma, Hepatoc

The ‘Patient Recruitment and Retention Services, 2019-2030{RootsAnalysis}

https://www.rootsanalysis.com/reports/view_document/patient-recruitment-and-retention-services-market-2019-2030/245.html   Key Inclusions §  A detailed assessment of the current market landscape, including information on drug developer(s), §  A detailed assessment of the current market landscape of companies offering patient recruitment and retention services, including information on over 10 types of patient outreach methods employed, types of services offered ([A] patient

Presently, close to 140 companies claim to be actively engaged in offering patient recruitment<RootsAnalysis>

A steadily increasing demand for study participants and the complexities associated with patient enrollment has imposed a significant burden on drug developer companies, prompting them to enlist the services of specialty service providers. Presently, close to 140 companies are actively offering patient recruitment and retention services. Majority of these players possess vast service portfolios and utilize diverse patient outreach methods to recruit study participants across different geographie

The patient recruitment and retention services market is projected to grow at an annualized rate of ~5%, till 2030<Roots>

Roots Analysis has done a detailed study on Patient Recruitment and Retention Services Marker, 2019-2030.”, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 300+ page report, which features 90+ figures and 140+ tables, please visit this -https://www.rootsanalysis.com/reports/view_document/patient-recruitment-and-retention-services-market-2019-2030/245.html   Key Market Insights §  Presently, close to

The patient recruitment and retention services market is estimated to be worth USD 5.3 billion in 2030: By RootsAnalysis:

Roots Analysis  is pleased to announce the publication of its recent study, titled, “Patient Recruitment and Retention Services Marker, 2019-2030.”   The report offers a comprehensive study of the current scenario and future potential of the players providing patient enrollment and retention services. The study features an in-depth analysis, highlighting the capabilities of the various stakeholders in this domain. In addition to other elements, the study includes: §  A detailed as

Growing at an annualized rate of over 35%, the large volume wearable injectors market: By Roots:

Roots Analysis has announced the addition of “Large Volume Wearable Injectors Market (5th Edition), 2020-2030: Focus on Bolus, Basal and Continuous Delivery Devices” report to its list of offerings.   The wide-spread prevalence of chronic diseases has compelled drug developers to innovate and design  better, more advanced healthcare solutions. Large volume wearable injectors were developed to specifically address certain challenges associated with the administration of high volume for

The “Proteome Profiling Services Market, 2020-2030{RootsAnalysis}

https://www.rootsanalysis.com/reports/proteome-profiling-services.html   Key Inclusions §  A detailed review of the overall landscape of companies offering proteome profiling services, along with information on type of service provider (industry and non-industry), year of establishment, company size, location of headquarters, service(s) offered for pre-proteome profiling (protein identification, protein quantification, protein separation, protein extraction and protein purificatio

The market is fragmented, featuring the presence of both industry and non-industry{Roots}

With the growing prominence of peptide-based therapeutics and personalized medicine, there is an increased demand for rapid, highly sensitive, and accurate quantification methods to analyze clinical specimens. As a result, proteome profiling has become an indispensable part of modern drug discovery and development process, as well as disease diagnosis.   To order this 290+ page report, which features 50+ figures and 100+ tables, please visit this - https://www.rootsanalysis.com/report

The proteome profiling services market is projected to grow at an annualized rate of ~15%(RootsAnalysis)

Roots Analysis has done a detailed study on “Proteome Profiling Services Market, 2020-2030., covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 290+ page report, which features 50+ figures and 100+ tables, please visit this - https://www.rootsanalysis.com/reports/proteome-profiling-services.html   Key Market Insights §  Over 200 players situated across the globe, claim to offer a variety of services fo

The proteome profiling services market is projected to be worth USD 16 billion by 2030(Roots)

Roots Analysis is pleased to announce the publication of its recent study, titled, “Proteome Profiling Services Market, 2020-2030.”   The report features an extensive study of the current market landscape and future opportunities associated with proteome profiling service providers. The study also features a detailed analysis of the key drivers and trends related to this evolving domain. Amongst other elements, the report includes:   §  A detailed review of the overall landsc

The “Prefilled Syringe Fill / Finish Service Providers, 2020-2030<RootsAnalysis>

https://www.rootsanalysis.com/reports/view_document/prefilled-syringe-fill-finish-services/301.html   Key Inclusions §  A detailed review of the overall landscape of companies offering contract fill / finish services for prefilled syringes, along with analyses based on a number of relevant parameters, such as year of establishment, company size, scale of operation (preclinical, clinical and commercial), location of the headquarters, location of fill / finish facilities, type of dr

Over 100 companies across the globe claim to provide contract fill / finish services<Roots>

According to the 10th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production, biopharmaceutical manufacturers have been reported to outsource more than 30% of their fill / finish operations to contract service providers. Owing to the benefits, such as inherent safety and ease-of-use, and provisions to reduce dosing errors, risk of occlusions, extravasation and phlebitis, several injectable drugs (Humira®, Enbrel®, Avastin®, PREVNAR 13®, ALPROLIX® and Benefix®), dilue

The prefilled syringe fill / finish services market is projected to grow: By RootsAnalysis:

Roots Analysis has done a detailed study on “Prefilled Syringe Fill / Finish Services Market, 2020-2030.” , covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 260+ page report, which features 60+ figures and 110+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/prefilled-syringe-fill-finish-services/301.html   Key Market Insights §  Over 100 companies across the glob
×
  • Create New...